Pfizer Inc
- SEC CIK
- 0000078003
- Latest filing
- Aug 13, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Feb 12, 2026. Long positions only; changes compare share counts with Q3 2025.
- Positions
- 18
- −3 vs. Q3 2025
- Portfolio value
- $236.5M
- −$201.0M (−45.9%) vs. Q3 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SENSSenseonics Holdings, Inc. | COM | 2,171 | $12.0K | <0.1% | 00.0% | UnchangedConverted for a 1-for-20 split | History |
| DNAGinkgo Bioworks Holdings, Inc. | CL A NEW | 2,928 | $24.3K | <0.1% | 00.0% | Unchanged | History |
| BOLTBolt Biotherapeutics, Inc. | COM NEW | 31,305 | $171.2K | 0.1% | 00.0% | Unchanged | History |
| ANTXAN2 Therapeutics, Inc. | COM | 715,295 | $815.4K | 0.3% | 00.0% | Unchanged | History |
| QTTBQ32 Bio Inc. | COM | 277,777 | $922.2K | 0.4% | 00.0% | Unchanged | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 953,834 | $1.29M | 0.5% | 00.0% | Unchanged | History |
| NXTCNextCure, Inc. | COM NEW | 157,646 | $2.24M | 0.9% | 00.0% | Unchanged | History |
| SPROSpero Therapeutics, Inc. | COM | 2,362,348 | $5.50M | 2.3% | 00.0% | Unchanged | History |
| BHVNBiohaven Ltd. | COM | 505,645 | $5.71M | 2.4% | 00.0% | Unchanged | History |
| CRDFCardiff Oncology, Inc. | COM | 2,411,575 | $6.78M | 2.9% | 00.0% | Unchanged | History |
| CRBUCaribou Biosciences, Inc. | COM | 4,690,431 | $7.46M | 3.2% | 00.0% | Unchanged | History |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 7,032,770 | $8.09M | 3.4% | 00.0% | Unchanged | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 2,970,022 | $15.6M | 6.6% | 00.0% | Unchanged | History |
| ALLOAllogene Therapeutics, Inc. | COM | 22,032,040 | $30.2M | 12.8% | 00.0% | Unchanged | History |
| WVEWave Life Sciences, Inc. | SHS | 1,875,000 | $31.9M | 13.5% | 00.0% | Unchanged | History |
| CELCCelcuity Inc. | COM | 349,406 | $34.8M | 14.7% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 3,457,815 | $41.0M | 17.3% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 5,376,344 | $44.0M | 18.6% | 00.0% | Unchanged | History |
Sold out since Q3 2025 (3)
Positions held at the end of Q3 2025 that are gone from this filing.